Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938199-116944487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 18.4;testis: 43.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.7;SK-BR-3: 11.2;U-2 OS: 5.4;U-266/84: 4.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	4	"midbrain: 7.3"	HPA068290			Approved	"Lipid droplets"				"Lipid droplets"		"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.4	0.8	0.7	1.8	1.2	0.3	4.9	0.0	0.9	0.3	4.5	0.0	0.0	0.2	1.1	0.8	8.1	0.2	0.4	0.1	0.5	0.6	1.3	0.1	2.9	1.0	0.4	0.5	0.1	0.1	0.1	0.0	0.6	0.5	8.4	0.7	4.0	2.1	0.2	0.2	1.1	0.8	18.4	0.1	0.3	7.2	43.6	0.1	0.0	0.2	0.2	0.5	10.2	5.6	1.1	1.0	3.3	0.9	1.5	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.5	0.0	0.2	0.1	2.3	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	2.3	0.1	0.4	0.8	0.1	1.1	2.0	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.2	0.0	0.5	0.0	0.0	0.1	5.4	0.2	0.0	1.6	4.0	0.0	2.9	0.1	0.3	3.3	0.9	0.6	0.6	0.4	0.3	0.6	0.5	0.4	0.2	1.1	0.5	0.6	3.1	1.5	0.6	1.0	2.0	0.1	0.7	1.2	0.0	0.4	0.5	0.6	0.4	0.5	0.5	0.1
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860934-222944639	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 206.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Lipid droplets"				Nucleoli	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: "	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (2.75e-4)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	14.7	17.0	22.8	9.9	26.0	16.3	51.5	19.4	45.9	15.3	16.5	16.1	11.6	12.7	10.9	18.4	28.3	9.0	11.8	22.7	20.9	22.8	17.9	22.3	15.6	10.5	19.6	21.2	11.7	10.3	206.1	8.8	19.1	24.4	44.4	16.7	14.4	34.2	15.5	19.1	11.4	12.7	12.2	22.2	9.7	28.3	13.7	14.2	13.5	17.3	11.2	8.7	14.6	15.4	15.0	22.5	21.8	16.8	16.6	20.1	16.5	9.9	17.6	27.0	29.3	11.8	29.3	7.5	12.7	33.0	15.2	32.2	15.8	25.7	4.8	7.4	12.1	29.4	5.8	28.3	19.8	8.6	11.1	11.2	14.3	17.7	26.0	7.4	5.5	15.1	40.1	25.2	44.0	16.6	21.2	18.3	21.5	21.2	14.4	8.7	13.7	9.2	7.9	22.9	8.1	21.9	40.9	14.2	10.6	7.5	20.3	92.7	10.2	18.1	11.4	10.2	16.3	8.8	9.3	6.5	3.1	16.5	11.0	6.9	30.9	16.6	14.6	21.8	20.1	16.8	19.3	11.6	12.8	14.6	15.7	15.0	18.7	16.7	21.8	16.6	15.9	22.5	9.5	16.5	22.8	26.0	19.4	45.9	20.9	22.8	19.6	21.2	24.4	14.2
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 95.3;pituitary gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;HAP1: 18.4;K-562: 7.4;NTERA-2: 9.6;SCLC-21H: 9.0;U-266/70: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067503	Approved		Approved	"Lipid droplets"				"Lipid droplets"		"HPA067503: "	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.5	95.3	21.9	0.6	19.8	0.8	2.2	13.9	14.7	0.7	1.0	3.1	1.2	0.7	0.6	0.9	1.0	0.6	6.3	0.6	26.5	1.5	10.6	19.4	5.5	0.5	1.1	7.0	0.6	1.3	1.1	35.4	2.4	4.9	1.1	1.0	4.9	0.7	2.4	0.6	1.5	0.7	0.6	0.4	0.7	1.0	1.1	5.3	0.0	4.2	0.0	0.7	5.4	0.4	4.1	2.2	8.4	1.7	1.7	3.4	0.4	0.4	1.6	12.4	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.3	0.1	0.2	0.3	0.0	0.1	18.4	0.1	0.0	0.7	3.4	3.1	1.5	1.1	0.0	0.2	0.1	0.0	3.8	0.0	0.1	0.0	7.4	2.0	0.0	1.5	0.1	0.1	9.6	3.3	0.0	0.3	1.6	0.0	0.4	9.0	2.2	2.7	1.8	0.1	4.7	0.0	0.6	0.3	1.5	0.4	0.8	10.8	3.0	0.4	0.6	0.1	0.0	4.9	1.7	4.8	2.0	1.3	3.2	2.5	2.2	2.6	0.9	4.1	3.4	1.8	8.4	1.7	1.0	2.2	2.7	0.4	21.9	19.8	13.9	14.7	26.5	1.5	1.1	7.0	4.9	5.3
ARSD		ENSG00000006756	"Arylsulfatase D"	P51689	X	2903970-2929351	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.7;EFO-21: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA004694, HPA063835"	Approved		Approved	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"HPA004694: AB_1078221, HPA063835: "	"unprognostic (3.92e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"prognostic favourable (5.21e-4)"	"unprognostic (5.90e-3)"	"unprognostic (6.32e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.18e-2)"	"unprognostic (3.93e-1)"	"prognostic favourable (1.97e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.11e-3)"	8.1	5.6	3.7	10.1	3.5	2.3	14.2	3.2	5.0	14.7	15.4	5.8	27.4	11.9	8.9	19.2	9.3	16.6	16.8	8.7	5.7	3.6	34.1	23.8	13.1	11.3	3.1	3.3	13.0	48.1	8.5	3.9	16.2	8.7	11.5	8.5	7.8	15.8	30.9	1.6	5.9	22.3	12.0	4.5	5.7	19.5	5.2	3.3	1.8	12.9	5.6	7.1	12.4	6.9	2.1	6.3	5.7	8.5	3.0	2.6	3.2	4.5	8.1	2.2	10.5	9.5	5.5	0.1	2.6	4.8	1.2	0.8	0.5	15.7	0.0	16.9	5.3	0.0	0.4	1.3	1.1	0.1	0.0	0.0	0.0	2.6	5.2	0.0	6.3	8.6	4.3	2.3	2.5	7.8	0.0	0.0	5.2	11.0	0.0	1.1	1.8	3.4	1.9	0.0	0.1	8.4	0.1	0.0	5.9	3.6	4.3	2.7	11.6	8.7	7.1	0.0	0.3	0.8	1.2	0.1	0.0	0.0	7.7	5.5	5.9	2.1	8.5	5.7	2.6	7.1	1.0	2.1	1.3	2.0	6.3	1.4	0.3	1.5	1.5	3.0	2.7	4.4	0.4	3.2	3.7	3.5	3.2	5.0	5.7	3.6	3.1	3.3	8.7	3.3
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677342-28682939	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 46.8;seminal vesicle: 52.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.8;SK-MEL-30: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"				Vesicles	"Nucleoli fibrillar center, Lipid droplets"	"HPA010819: , HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favourable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	2.0	24.7	6.7	1.8	6.9	3.0	13.6	2.2	6.3	3.9	2.3	12.9	15.5	1.1	10.1	2.0	1.1	2.8	3.0	22.8	6.7	6.4	11.2	12.9	5.7	3.1	12.0	2.9	46.8	3.9	7.4	4.5	20.9	10.5	6.5	2.8	30.4	3.8	52.4	1.2	2.7	1.1	12.7	10.8	9.0	2.3	4.8	7.9	0.1	0.6	2.1	1.3	13.8	11.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.2	10.8	1.1	0.6	1.3	0.0	6.5	2.6	0.9	4.2	2.7	42.8	4.5	0.1	1.6	1.9	3.2	2.6	0.4	1.9	2.6	6.0	10.1	1.6	16.2	1.5	0.6	13.4	1.0	0.6	2.8	0.4	0.6	5.7	4.9	0.8	17.8	0.0	0.7	19.6	2.7	0.1	2.0	0.9	3.4	10.4	1.8	1.4	3.5	20.8	51.1	6.1	0.7	0.0	2.8	2.1	4.5	1.3	0.1	3.7	0.0	0.2	2.3	17.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.7	6.9	2.2	4.8	6.7	6.4	12.0	2.9	10.5	7.9
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418865-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;ovary: 47.7;testis: 86.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 56.4;ASC TERT1: 71.2;EFO-21: 42.2;HUVEC TERT2: 60.9;TIME: 96.3"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"				"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favourable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	8.2	1.9	14.1	2.0	40.6	1.7	6.3	3.5	50.3	1.9	3.4	85.9	0.5	2.2	2.7	4.6	4.6	4.2	18.9	4.0	28.7	13.0	3.2	2.8	2.8	2.1	59.5	17.1	47.7	2.1	1.8	5.5	4.2	37.3	5.1	2.5	0.6	4.7	4.2	1.7	3.6	2.6	2.8	80.6	2.6	2.5	86.1	47.9	0.0	2.0	0.9	2.0	6.3	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	56.4	71.2	0.0	0.7	3.6	4.6	7.7	0.0	9.4	0.0	42.2	5.7	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	3.2	17.4	0.0	0.0	26.0	0.0	25.3	0.0	60.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	96.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.1	40.6	3.5	25.0	28.7	13.0	59.5	17.1	37.3	47.9
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 140.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"				"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: "	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favourable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favourable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	27.1	23.1	21.4	22.4	21.0	24.2	38.8	21.8	26.6	25.3	24.8	26.6	16.7	20.8	31.2	22.8	26.6	27.3	18.8	29.0	21.5	12.9	23.8	20.6	26.5	39.4	24.7	17.1	31.1	27.9	30.7	26.1	30.4	20.5	25.2	27.9	20.4	23.0	23.8	140.1	35.5	30.9	26.7	25.6	38.3	24.3	26.6	24.3	43.8	26.0	31.5	34.1	22.4	26.7	13.0	17.3	18.3	11.8	7.2	11.2	3.8	38.1	57.2	32.2	34.5	50.4	62.1	24.4	28.6	48.0	46.2	39.8	27.3	26.7	35.4	30.5	51.1	32.0	42.2	44.1	51.6	52.5	35.8	24.7	38.4	46.9	46.8	28.1	46.8	50.0	53.7	52.8	56.4	49.1	22.0	26.3	43.3	24.1	31.3	30.1	22.4	24.3	38.1	28.7	28.2	36.7	20.1	12.4	35.5	22.8	22.9	30.5	21.5	23.2	27.9	33.7	29.0	26.9	53.7	22.7	19.8	18.2	43.4	38.8	34.8	6.3	11.8	18.3	10.5	11.7	8.5	13.0	10.1	11.0	8.4	12.4	7.8	11.2	15.6	7.2	7.7	17.3	9.6	3.8	21.4	21.0	21.8	26.6	21.5	12.9	24.7	17.1	20.5	24.3
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039469	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.6;Hep G2: 18.2;Karpas-707: 5.1;RPMI-8226: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Group enriched"	"Detected in many"	6	"monocytes: 3.0;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Intracellular and membrane"			Vesicles	"Lipid droplets"	"HPA037972: , HPA037973: "	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favourable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	6.8	11.7	2.2	3.1	3.0	0.3	3.9	0.9	2.4	10.3	3.4	3.9	7.4	0.9	6.3	5.7	5.0	4.4	7.0	13.3	2.6	2.1	6.9	3.1	4.3	5.8	4.3	2.0	7.9	6.3	18.4	1.9	2.7	2.9	8.3	1.7	5.0	5.4	10.4	3.3	5.4	1.6	5.4	4.6	2.0	4.7	2.7	2.3	0.8	8.9	5.0	1.2	4.4	8.1	0.0	0.0	0.0	3.0	0.6	4.0	0.3	0.0	0.6	0.3	2.9	0.6	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.3	5.6	0.2	0.4	4.0	1.5	0.0	0.0	4.6	0.0	0.1	18.2	1.1	0.0	1.2	2.4	1.4	0.0	1.0	0.5	0.0	5.1	0.0	1.2	0.0	0.0	3.0	0.4	0.0	1.3	6.1	0.1	0.0	1.6	0.0	0.1	0.4	0.1	0.3	0.1	0.5	1.9	2.4	2.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	3.0	4.0	0.0	1.8	0.9	0.0	0.0	1.1	0.2	0.0	0.6	2.0	0.0	0.0	0.3	2.2	3.0	0.9	2.4	2.6	2.1	4.3	2.0	2.9	2.3
FAF2	"ETEA, KIAA0887, UBXD8, UBXN3B"	ENSG00000113194	"Fas associated factor family member 2"	Q96CS3	5	176447628-176510074	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065968, HPA071246, HPA073828"	Approved		Enhanced	"Endoplasmic reticulum,Lipid droplets"				"Lipid droplets"	"Endoplasmic reticulum"	"HPA065968: , HPA071246: , HPA073828: "	"unprognostic (6.25e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.02e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavourable (1.79e-4)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (6.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.48e-1)"	21.1	27.7	17.5	16.5	28.5	21.7	20.8	25.4	28.3	21.5	19.2	24.4	17.4	17.2	22.3	21.5	23.0	21.0	18.0	15.1	16.8	18.9	20.5	34.2	17.8	17.2	16.4	15.9	29.3	25.9	32.4	31.5	32.0	25.5	22.3	23.1	24.6	20.1	18.6	15.3	25.5	22.6	22.2	14.5	21.0	18.8	31.9	14.2	30.0	23.1	15.2	24.3	20.7	17.5	7.2	10.9	10.0	14.9	12.4	13.1	7.5	13.9	15.9	15.8	17.5	22.4	17.9	21.6	18.3	21.0	20.9	22.7	20.6	25.3	12.2	20.7	19.3	21.6	22.6	46.4	29.0	48.6	12.4	8.0	16.2	10.0	22.9	17.3	10.5	23.5	20.5	25.5	21.3	17.3	11.4	16.7	19.9	23.2	15.1	9.2	12.7	13.5	15.0	13.7	13.6	17.7	18.5	14.0	15.0	22.3	19.4	20.2	22.8	13.8	19.3	28.8	15.6	15.8	24.4	14.4	15.3	16.0	18.2	12.4	25.1	10.0	9.2	6.1	10.0	7.6	12.2	7.2	8.2	10.5	10.9	7.0	10.7	9.5	7.8	12.4	14.9	7.5	13.1	7.5	17.5	28.5	25.4	28.3	16.8	18.9	16.4	15.9	25.5	14.2
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109691312-109825428	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Approved	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: "	"prognostic unfavourable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favourable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favourable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	11.0	13.5	14.5	12.2	30.3	14.0	14.4	13.5	35.3	12.4	13.2	11.0	5.0	8.3	11.3	17.0	11.7	10.5	13.4	10.1	14.5	18.5	13.2	8.7	19.2	16.6	17.6	17.7	12.2	9.9	25.4	15.4	12.6	19.0	11.6	14.6	9.7	17.0	12.0	12.1	9.2	10.7	14.7	16.0	17.3	11.4	12.6	12.9	18.1	12.6	8.5	15.0	12.5	10.5	15.5	15.9	12.8	20.0	8.0	7.7	9.8	6.2	6.5	9.8	11.7	10.4	14.4	6.2	8.1	11.7	6.7	18.0	4.8	6.6	16.8	5.2	13.1	4.7	9.6	6.4	15.6	10.2	11.7	9.4	6.5	4.8	9.6	8.8	8.4	7.4	8.4	11.4	7.9	13.6	5.5	7.2	9.4	5.8	9.0	7.6	5.1	3.2	6.3	4.5	5.8	11.3	15.5	10.9	10.2	5.3	7.8	16.4	5.6	14.7	9.5	4.2	3.6	6.1	6.9	3.4	2.4	8.1	22.3	6.3	3.8	11.5	20.0	12.8	7.7	19.7	6.0	14.6	5.7	7.3	15.9	15.5	7.0	6.8	8.7	8.0	13.5	6.9	6.6	9.8	14.5	30.3	13.5	35.3	14.5	18.5	17.6	17.7	19.0	12.9
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell line enhanced"	"Detected in some"		"A-431: 30.8;HaCaT: 24.6;HBEC3-KT: 32.8;hTCEpi: 43.8;hTERT-HME1: 18.4;RT4: 12.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"				"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: "	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.0	24.6	0.0	32.8	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	43.8	0.0	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.7	0.0	0.0	0.0	1.1	12.9	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0
HBQ1	HBQ	ENSG00000086506	"Hemoglobin subunit theta 1"	P09105	16	180453-181181	"Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7"	"Group enriched"	"Detected in some"	7	"HEL: 13.1;Hep G2: 9.1;K-562: 32.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;T-cells: 2.3"					"Low region specificity"	"Detected in all"			HPA062473	Enhanced		Approved	"Lipid droplets"			47000	"Lipid droplets"		"HPA062473: "		"unprognostic (4.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.02e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.55e-1)"	0.5	0.6	12.2	0.5	10.0	29.4	0.5	0.6	6.3	0.5	0.5	0.2	0.0	0.6	0.5	0.5	0.5	0.5	0.5	0.9	5.6	4.0	0.5	0.5	2.1	0.5	2.2	3.7	0.6	0.5	0.5	0.5	2.6	2.4	0.6	0.5	0.0	0.8	0.5	0.9	0.5	0.5	0.5	0.7	2.8	0.5	1.3	0.3	0.0	0.5	0.0	0.5	0.6	10.7	0.4	0.2	2.5	0.0	0.0	2.3	8.0	0.0	0.7	0.2	2.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	2.2	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	13.1	0.5	9.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	32.4	0.0	0.0	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.2	0.4	0.0	0.3	1.8	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	2.3	0.4	0.7	1.6	0.1	0.0	0.5	1.2	2.5	0.0	0.0	0.2	0.0	8.0	12.2	10.0	0.6	6.3	5.6	4.0	2.2	3.7	2.4	0.3
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4;esophagus: 71.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"			"Lipid droplets"	Nucleoplasm	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavourable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	24.5	5.2	25.3	5.5	34.2	14.1	16.2	8.6	53.9	15.7	14.4	6.4	2.8	4.7	9.1	6.3	71.4	7.9	7.2	16.7	25.1	8.5	10.4	10.3	13.2	4.9	22.4	3.1	22.9	5.0	3.0	4.2	25.7	46.5	7.0	6.2	2.8	7.7	6.1	5.2	14.4	4.4	6.9	66.4	3.0	6.4	10.1	21.1	1.7	5.6	6.9	6.0	60.5	18.6	9.2	5.9	31.7	3.6	6.9	3.3	2.0	11.0	23.2	12.7	13.8	17.4	6.4	23.9	4.0	5.0	8.5	9.4	5.8	10.1	7.5	3.2	6.0	7.1	7.1	8.6	10.9	4.1	6.5	4.6	4.9	5.2	3.9	7.2	6.3	10.6	7.5	6.7	4.5	6.9	6.6	3.1	8.4	13.5	21.7	13.2	15.7	10.3	16.4	5.9	11.7	4.7	16.4	12.2	11.2	6.3	44.1	7.8	35.9	7.1	5.0	10.9	5.4	8.2	5.0	3.1	2.2	9.6	20.6	11.2	9.4	9.2	3.5	31.7	2.3	3.6	3.3	7.8	2.9	2.8	3.4	9.2	3.0	2.9	1.4	6.9	2.7	5.9	1.9	2.0	25.3	34.2	8.6	53.9	25.1	8.5	22.4	3.1	46.5	21.1
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"			28000000	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: "	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	5.5	11.0	5.3	6.2	9.3	75.2	8.6	5.2	8.0	5.5	8.3	6.0	6.0	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6.0	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6.0	8.4	13.0	9.3	5.7	4.8	7.7	19.1	12.0	14.0	3.8	7.4	9.4	9.1	14.0	6.7	11.9	5.4	6.7	10.1	7.3	8.3	10.8	9.3	17.3	14.5	14.2	16.4	9.3	13.0	10.0	14.2	6.9	9.7	10.2	23.3	5.6	12.6	9.9	8.7	7.6	7.3	9.1	17.0	13.0	5.0	34.5	6.3	8.5	36.8	8.4	16.8	7.5	8.9	9.7	6.6	13.8	10.8	8.4	7.4	10.1	5.9	9.2	6.4	15.7	12.1	4.6	8.2	6.2	8.0	8.5	3.4	4.0	8.4	5.4	11.5	9.7	12.0	14.0	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8.0	5.9	5.5	8.8	4.5	8.4	7.5
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.6	5.2	13.0	16.0	22.1	7.4	5.7	9.1	3.8	7.0	8.8	68.2	0.0	11.2	5.9	0.2	15.1	1.2	4.2	16.8	3.2	14.7	5.9	29.8	9.1	26.1	27.3	15.6	0.4	5.2	1.8	7.3	15.2	7.6	6.9	0.4	5.3	32.0	8.9	1.7	14.6	4.8	17.2	10.5	16.3	1.7	16.7	11.3	0.3	19.4	0.0	25.5	6.1	2.6	11.7	10.4	2.9	3.7	1.5	1.6	4.8	18.5	17.7	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.0;Hep G2: 22.7;HMC-1: 35.2;U-2197: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"				"Lipid droplets"		"HPA050521: , HPA060847: "	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	6.9	8.0	0.8	4.0	2.9	10.5	0.5	8.7	13.7	1.7	3.6	0.5	12.1	0.4	2.9	10.6	2.1	0.7	1.2	0.9	31.0	1.9	0.5	6.3	22.7	2.7	0.1	35.2	5.0	2.1	8.3	1.6	0.7	1.6	0.3	6.5	14.8	0.2	4.9	0.6	1.1	0.8	2.8	7.6	5.3	0.4	3.0	1.5	1.1	5.6	0.7	11.0	0.5	4.0	3.6	1.0	34.3	0.9	0.6	5.0	0.4	14.0	0.8	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7
KIAA1328		ENSG00000150477	KIAA1328	Q86T90	18	36829106-37232172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040946	Approved		Approved	"Nuclear speckles,Vesicles,Lipid droplets"				"Nuclear speckles"	"Vesicles, Lipid droplets"	"HPA040946: AB_10794998"	"unprognostic (3.66e-2)"	"unprognostic (5.37e-4)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.64e-3)"	11.1	8.1	14.0	10.7	14.3	23.1	11.1	27.4	13.0	13.7	7.5	13.0	6.1	9.2	12.6	11.1	7.9	9.4	8.3	9.8	10.7	8.5	9.2	7.7	10.4	8.5	12.3	9.0	18.3	6.9	9.0	18.6	9.7	10.3	11.1	7.4	10.9	10.9	9.5	11.4	15.7	9.7	15.8	13.2	8.9	10.7	19.6	14.4	5.4	11.1	9.7	11.5	10.1	11.0	12.7	5.7	17.1	7.4	7.5	10.4	3.6	14.5	4.4	6.5	7.9	2.3	3.1	6.3	5.6	2.1	2.6	1.9	7.7	9.7	9.5	21.1	2.1	6.5	2.6	2.7	3.4	7.4	2.7	12.4	12.0	4.8	1.8	7.9	6.0	3.2	3.0	3.1	2.7	2.3	9.8	23.7	2.6	14.3	5.5	6.0	14.9	7.7	7.9	6.8	7.0	2.5	14.8	7.1	8.2	7.6	9.2	3.7	14.8	4.5	8.0	13.0	19.0	7.5	6.7	18.8	24.0	7.5	6.6	5.7	8.5	17.1	6.8	9.2	9.0	4.8	10.4	7.5	8.0	7.4	3.1	12.7	10.1	8.4	15.1	7.5	7.4	5.7	8.9	3.6	14.0	14.3	27.4	13.0	10.7	8.5	12.3	9.0	10.3	14.4
KRT222	"KA21, KRT222P, MGC45562"	ENSG00000213424	"Keratin 222"	Q8N1A0	17	40654665-40665181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 15.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA054586, HPA068724, HPA069774"	Enhanced		Approved	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"HPA054586: AB_2682532, HPA068724: , HPA069774: "	"unprognostic (2.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.41e-2)"	3.8	5.0	9.6	0.7	18.3	0.6	1.3	15.6	21.7	2.3	1.8	0.2	0.9	1.2	1.9	11.8	1.2	1.2	8.3	1.0	10.0	10.0	1.3	9.4	1.4	1.1	8.6	13.4	0.9	1.7	1.6	5.2	0.6	14.3	3.2	2.3	0.8	0.7	4.6	0.6	0.8	2.3	3.1	3.3	3.4	1.0	1.4	3.3	0.0	1.2	0.3	1.1	2.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	18.3	15.6	21.7	10.0	10.0	8.6	13.4	14.3	3.3
LPCAT1	"AGPAT10, AGPAT9, AYTL2, FLJ12443"	ENSG00000153395	"Lysophosphatidylcholine acyltransferase 1"	Q8NF37	5	1456480-1523977	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 35.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.2;EFO-21: 32.9;PC-3: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012501, HPA022268"	Enhanced		Supported	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA012501: AB_1845224, HPA022268: AB_1845225"	"unprognostic (5.33e-3)"	"prognostic unfavourable (7.11e-5)"	"unprognostic (3.11e-1)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (3.13e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (1.88e-8)"	"unprognostic (5.90e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.08e-2)"	"prognostic favourable (4.90e-5)"	"unprognostic (4.89e-2)"	"prognostic unfavourable (2.64e-7)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.03e-1)"	9.8	5.6	5.2	9.0	5.7	5.1	7.4	9.2	9.5	5.4	7.5	2.9	4.5	3.9	7.0	3.2	3.2	5.9	5.8	4.3	5.3	5.2	4.9	3.1	35.6	8.5	3.2	3.7	5.0	5.4	3.1	5.6	10.0	4.6	5.2	2.3	13.6	4.5	4.4	3.5	3.2	5.9	5.5	3.3	28.8	9.4	3.0	2.9	5.8	4.7	1.4	8.1	6.6	10.6	0.9	0.7	2.4	1.7	1.7	3.6	0.6	2.0	3.0	0.5	3.2	0.3	0.5	34.2	7.7	0.4	0.4	0.3	1.1	0.9	6.7	32.9	0.2	5.7	0.6	0.2	0.2	16.2	13.9	1.6	4.8	2.0	0.6	1.7	4.6	0.6	0.1	0.3	0.1	0.4	3.6	1.2	0.0	4.2	6.3	2.6	12.0	22.9	12.0	0.5	4.9	1.3	2.7	4.3	4.2	6.1	5.5	1.8	2.6	2.6	3.8	0.6	7.5	2.3	2.7	4.3	4.1	1.5	1.4	2.8	2.0	0.0	0.6	0.8	3.6	1.7	3.6	0.9	0.8	1.8	0.7	0.7	0.1	1.0	2.4	1.7	1.2	0.2	0.8	0.6	5.2	5.7	9.2	8.0	5.3	5.2	3.2	3.7	4.6	2.9
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.5;HaCaT: 25.7;HL-60: 28.7;HMC-1: 47.8;WM-115: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favourable (3.43e-4)"	"prognostic favourable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	9.4	1.2	1.0	0.1	3.3	1.2	1.7	4.0	3.9	2.0	2.0	2.1	33.5	0.0	13.8	5.7	25.7	0.6	5.5	3.2	2.5	2.8	9.6	3.1	4.9	1.2	28.7	47.8	0.6	5.6	2.2	1.8	15.4	0.4	0.1	3.3	0.6	0.0	11.6	1.5	0.1	2.9	1.1	1.4	1.9	3.7	0.6	7.4	7.7	3.1	5.6	1.3	7.3	17.3	0.3	0.0	2.0	2.7	0.1	0.0	0.0	0.8	14.0	34.0	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9
LRP3	"hLRp105, LRP-3"	ENSG00000130881	"LDL receptor related protein 3"	O75074	19	33177603-33208867	"Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell line enhanced"	"Detected in many"		"THP-1: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.8;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041658			Approved	"Lipid droplets"				"Lipid droplets"		"HPA041658: "	"unprognostic (3.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (6.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	23.5	16.6	28.3	5.1	33.1	15.3	15.6	14.2	41.2	12.1	7.8	6.6	4.4	7.1	11.2	8.8	7.4	12.4	8.2	10.9	27.6	13.0	4.2	15.5	5.3	3.2	15.4	19.4	50.0	16.8	9.8	10.3	3.8	11.0	15.5	3.4	10.0	14.4	12.7	21.9	5.0	6.6	10.6	6.3	4.8	7.0	5.6	7.7	0.0	9.5	4.7	3.1	9.0	9.1	0.0	0.0	0.6	2.8	0.5	0.1	0.7	0.0	20.4	5.6	20.2	14.1	5.4	4.2	5.2	5.1	4.8	1.8	5.8	0.2	0.0	13.7	6.4	0.0	5.4	0.5	0.4	0.0	11.0	0.0	4.6	20.4	5.4	7.3	0.7	8.0	4.8	1.3	0.7	3.9	0.0	0.0	6.1	18.8	0.0	8.2	11.5	1.0	0.0	2.6	0.0	0.0	8.1	12.4	18.7	8.4	0.0	1.5	8.6	25.8	0.0	10.0	9.0	14.9	2.9	0.0	0.0	0.1	0.0	12.3	2.9	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	2.6	0.0	0.0	0.7	28.3	33.1	14.2	41.2	27.6	13.0	15.4	19.4	11.0	7.7
LUZP6	"MPD6, MTPNUT"	ENSG00000267697	"Leucine zipper protein 6"	Q538Z0	7	135927274-135927450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MOLT-4: 9.8;SK-MEL-30: 19.3"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 2.4;naive CD8 T-cell: 2.7;plasmacytoid DC: 2.9;T-reg: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;T-cells: 4.4"									HPA077907			Approved	"Lipid droplets"				"Lipid droplets"		"HPA077907: "																		1.2	1.2	2.3	1.2	3.5	1.2	1.2	1.2	1.8	3.6	1.2			1.2	1.2	1.2	4.9	2.9	1.2	1.2	2.1	0.8	1.2	1.3	1.2	1.2	1.9		1.2	1.2	1.2	2.0	1.2		1.2	1.2		1.2	1.2	7.2	1.2	1.2	1.2	0.5	3.4	1.2	1.2			1.2		1.2	1.2	1.2	0.5	2.9	0.1	0.0	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	2.4	2.7	0.0	0.6	0.0	2.9	4.4	0.0										
METTL7A	DKFZP586A0522	ENSG00000185432	"Methyltransferase like 7A"	Q9H8H3	12	50923472-50932517	"Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.5;thyroid gland: 120.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.5;Karpas-707: 75.4;RPMI-8226: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 29.7;classical monocyte: 12.7;eosinophil: 25.8;intermediate monocyte: 14.2;memory B-cell: 13.6;myeloid DC: 11.5;naive B-cell: 14.7;non-classical monocyte: 20.2;plasmacytoid DC: 10.1"	"Low lineage specificity"	"Detected in all"											HPA017434			Supported	"Lipid droplets"			140000	"Lipid droplets"		"HPA017434: AB_1853835"	"unprognostic (2.31e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.48e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (8.64e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-2)"	38.3	35.2	25.3	10.3	32.1	4.4	44.8	22.7	21.5	21.4	36.6	17.8	15.6	18.3	16.1	13.0	19.9	29.1	25.2	12.8	27.1	12.6	43.0	126.5	26.4	24.5	29.3	22.2	29.0	35.6	11.9	10.5	7.9	26.5	13.6	20.0	13.0	19.0	14.2	16.1	10.9	22.3	19.4	32.2	16.0	28.1	17.3	25.9	3.6	120.3	9.4	16.0	29.1	15.8	14.7	11.5	29.7	20.2	3.8	3.7	5.4	0.2	0.0	1.8	10.9	75.5	21.7	23.8	0.2	1.8	0.1	0.3	0.9	1.0	12.8	0.9	0.8	1.5	1.1	1.2	0.0	1.3	2.8	3.1	2.3	7.3	16.4	0.7	6.6	22.6	0.1	0.1	0.0	5.0	1.8	75.4	0.7	0.0	0.6	3.3	8.9	0.0	0.7	0.1	41.6	3.5	13.5	4.2	6.9	0.2	7.4	0.2	21.6	0.7	2.9	0.1	0.2	0.9	0.0	3.8	0.6	5.7	1.4	1.5	0.0	29.7	12.7	25.8	1.0	14.2	0.6	13.6	0.4	0.8	11.5	14.7	0.1	0.7	0.8	3.8	20.2	10.1	3.7	5.4	25.3	32.1	22.7	20.0	27.1	12.6	29.3	22.2	26.5	25.9
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"			12000	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavourable (8.37e-5)"	"prognostic favourable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	15.8	27.4	10.2	18.2	15.3	31.1	10.2	21.2	23.6	9.3	20.4	14.7	14.9	32.9	12.7	7.2	14.1	11.0	15.5	10.5	12.2	8.5	13.3	48.3	15.5	19.8	9.7	9.0	12.1	41.3	9.5	11.5	11.3	10.8	13.3	9.7	13.0	18.7	9.9	16.3	14.9	27.8	9.5	8.0	20.6	18.9	17.2	12.1	11.8	11.8	11.8	13.2	9.4	11.8	5.3	17.8	8.8	12.2	4.3	7.7	7.1	27.1	31.8	7.9	24.6	7.8	6.5	20.6	30.0	12.6	22.6	18.4	43.1	15.8	16.5	26.1	19.7	32.3	9.4	22.8	5.0	21.5	21.5	11.5	19.6	29.3	15.6	20.5	21.5	11.3	14.5	18.2	9.9	12.5	29.4	18.5	10.3	24.1	17.8	21.9	22.4	22.5	28.7	8.4	26.2	13.3	18.7	17.1	16.9	12.1	22.6	19.0	16.4	23.6	16.9	19.7	17.1	32.0	36.2	23.2	21.0	12.7	20.7	26.3	30.1	1.1	11.9	8.8	6.9	12.2	6.1	5.3	4.2	7.7	8.7	4.4	4.6	6.1	7.3	4.3	4.9	17.8	3.8	7.1	10.2	15.3	21.2	23.6	12.2	8.5	9.7	9.0	10.8	12.1
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"				"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favourable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favourable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	43.6	16.1	21.9	11.4	18.9	14.4	12.4	8.7	11.7	15.9	20.3	22.2	23.9	21.6	29.4	11.8	22.5	28.5	40.2	14.1	7.2	16.3	8.8	15.7	22.4	13.8	8.8	7.2	17.6	15.6	31.1	7.9	14.7	14.6	9.8	12.0	19.3	8.7	11.5	8.7	19.4	6.5	15.9	17.7	33.0	18.1	7.9	9.0	7.8	11.7	9.2	7.7	11.3	12.4	7.4	12.3	17.8	16.7	13.9	9.3	37.2	13.7	13.8	7.0	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.8;HHSteC: 171.3"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"				"Lipid droplets"		"CAB037331: , HPA016607: "	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.2	2.3	197.8	27.0	35.9	9.1	7.1	5.5	6.3	4.3	0.6	0.0	0.1	18.6	0.3	3.1	0.0	9.6	11.5	0.0	15.1	0.4	16.1	171.3	1.8	27.8	28.5	3.2	13.6	0.0	6.8	2.7	3.3	21.6	0.7	4.1	6.2	4.3	5.6	10.0	1.5	0.1	0.0	10.6	0.2	5.3	4.2	1.0	9.0	2.2	4.0	10.7	0.0	1.7	8.6	0.0	2.0	2.0	6.1	0.0	3.1	0.8	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867768	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Enhanced	"Lipid droplets"			9300000	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: "	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favourable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.27e-5)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	13.2	28.9	7.4	16.9	16.3	25.5	12.7	2.8	10.8	17.8	17.5	37.9	4.2	29.1	9.3	12.6	46.9	9.5	14.8	12.4	9.2	7.0	10.4	19.6	9.9	13.6	32.4	8.3	23.4	8.1	3.1	3.9	28.3	17.8	11.0	8.9	6.7	18.1	9.7	40.0	31.8	38.6	11.1	26.7	13.1	11.1	13.6	25.1	20.0	13.1	35.8	29.1	14.1	19.7	12.5	28.9	45.9	37.5	9.4	8.4	19.0	27.7	16.4	11.5	10.4	12.7	41.4	5.0	40.5	37.8	32.7	30.3	10.7	25.4	14.4	9.2	50.9	12.7	5.2	22.8	19.3	16.4	7.5	15.6	9.3	19.6	9.1	11.1	23.8	32.3	9.5	23.2	5.0	17.0	23.7	6.4	39.6	11.4	15.8	15.0	8.6	26.7	27.2	15.5	8.1	27.8	6.4	0.5	5.4	12.6	11.5	9.9	14.6	25.2	25.3	17.4	17.2	69.6	20.8	9.0	11.5	9.9	52.4	15.8	20.0	28.3	37.5	16.1	3.8	26.2	3.8	12.5	6.7	4.3	28.9	9.3	5.4	3.4	45.9	9.4	18.0	21.4	8.4	19.0	7.4	16.3	2.8	10.8	9.2	7.0	32.4	8.3	17.8	25.1
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"			11000	"Lipid droplets, Plasma membrane"	"Vesicles, Cytosol"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;RT4: 5.0;SH-SY5Y: 4.7;T-47d: 10.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 14.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077050			Supported	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"HPA077050: "	"prognostic favourable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favourable (2.16e-4)"	20.9	1.7	8.0	2.9	5.2	3.9	6.5	4.2	5.8	1.8	3.3	2.0	10.5	1.6	1.6	5.5	1.9	3.1	1.9	12.0	7.8	1.4	5.8	44.6	2.8	1.5	3.4	2.6	25.8	30.1	0.5	6.2	0.6	3.7	4.5	0.9	3.4	40.3	4.6	40.8	1.7	1.3	1.5	1.7	1.8	11.5	1.4	4.2	0.0	2.2	6.0	1.1	3.7	5.7	0.6	0.4	14.7	0.5	0.8	0.4	0.1	0.5	0.3	1.1	3.8	2.8	0.1	5.5	0.2	0.2	0.2	0.1	0.4	1.0	0.3	1.2	0.2	0.4	0.0	0.0	0.0	0.5	0.4	0.3	1.4	1.7	0.6	0.4	0.9	0.7	0.0	0.0	0.1	0.3	1.2	0.5	0.3	0.9	0.3	0.9	0.7	0.5	0.3	0.2	3.4	0.3	5.0	0.7	4.7	0.5	0.8	0.0	10.4	0.7	1.0	0.6	0.5	0.5	0.3	0.6	0.2	0.2	0.5	1.1	0.2	1.5	0.5	0.8	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.4	14.7	0.8	0.3	0.4	0.2	0.1	8.0	5.2	4.2	5.8	7.8	1.4	3.4	2.6	3.7	4.2
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"				"Lipid droplets"	Nucleoplasm	"HPA055173: , HPA062602: , HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.4	8.2	1.7	4.4	64.1	5.7	11.0	11.1	9.0	7.0	6.2	6.9	10.5	6.2	6.6	8.3	9.4	2.5	4.6	2.1	7.9	22.7	8.5	3.6	11.1	21.0	5.8	10.8	11.2	6.0	4.7	5.4	5.7	7.2	6.3	6.2	6.1	7.8	12.9	4.9	17.6	7.6	3.7	13.8	6.8	2.4	6.3	8.4	20.6	17.6	6.4	7.5	6.8	10.2	6.3	4.9	4.1	5.0	24.3	15.0	5.2	15.8	8.4	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294612-73325281	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 134.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.6;BJ: 33.4;CACO-2: 29.8;HDLM-2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.4;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"				"Lipid droplets"		"HPA049199: "	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	18.3	3.2	2.7	9.5	3.3	0.7	11.8	1.7	2.8	8.2	18.7	2.9	10.0	13.6	5.9	5.8	9.4	4.4	21.9	9.6	2.3	2.4	19.6	37.5	8.7	4.8	4.1	1.7	4.9	14.8	3.7	17.9	20.9	8.7	12.4	6.4	134.3	22.6	5.7	3.4	4.4	34.1	14.0	6.9	5.6	15.3	8.0	2.1	2.0	3.5	7.3	6.5	12.8	6.5	0.6	0.7	4.4	0.6	0.2	2.3	0.5	4.1	12.1	1.3	5.6	46.6	3.4	12.4	33.4	5.4	1.3	2.2	29.8	12.0	2.9	4.4	18.6	11.1	6.1	4.8	2.7	33.5	15.3	5.2	12.0	9.1	1.8	2.4	5.7	2.0	6.2	5.2	4.9	4.9	5.9	4.3	2.2	1.8	2.5	1.0	1.6	5.9	2.2	1.4	1.7	9.0	6.0	0.8	1.0	2.8	20.8	1.7	4.1	1.3	7.4	2.0	3.4	9.1	2.5	2.8	2.9	2.4	1.6	2.2	4.6	4.4	0.6	1.1	1.2	0.3	0.7	0.6	1.3	1.4	0.7	0.1	2.3	1.2	0.8	0.2	0.5	0.2	0.7	0.5	2.7	3.3	1.7	1.8	2.3	2.4	4.1	1.7	8.7	2.1
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905214-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"				"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favourable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavourable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favourable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	17.3	16.5	17.1	16.0	21.7	10.2	18.4	16.5	28.2	19.5	13.2	46.3	21.1	19.3	16.3	20.4	22.0	37.2	19.4	8.5	19.3	19.5	19.9	21.5	19.3	13.9	22.1	14.6	23.7	28.0	12.7	23.2	24.2	27.6	19.5	9.8	21.4	41.1	21.4	9.1	19.2	18.9	12.1	42.1	17.2	21.8	15.9	20.3	10.3	23.8	10.6	18.2	15.7	13.9	6.4	14.2	2.5	5.9	7.1	5.0	3.7	22.8	22.9	10.4	25.4	21.0	13.1	12.5	14.9	13.9	16.3	19.9	18.6	22.1	9.4	14.5	11.9	27.4	9.9	15.1	6.1	14.8	8.9	6.5	8.1	17.8	27.0	6.5	10.1	20.1	9.6	14.2	8.6	11.1	14.8	10.7	9.4	27.4	8.7	12.7	17.1	7.7	10.9	7.6	14.2	20.1	20.3	14.8	19.5	9.4	22.7	12.4	22.1	17.1	11.8	20.1	13.9	35.9	15.7	26.0	25.6	8.4	26.6	11.0	12.9	1.9	5.2	2.0	5.0	5.9	2.7	6.4	3.5	3.2	5.7	4.6	2.1	3.7	2.5	7.1	5.0	14.2	2.7	3.7	17.1	21.7	16.5	28.2	19.3	19.5	22.1	14.6	27.6	20.3
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;liver: 33.9"	"Group enriched"	"Detected in many"	4	"A549: 13.7;CACO-2: 13.1;Hep G2: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"		840000	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	1.2	5.0	8.2	9.2	5.6	0.2	1.9	17.8	9.0	2.5	34.3	4.9	3.2	25.9	2.1	16.6	1.8	3.1	25.9	1.6	4.9	5.0	9.5	33.9	2.9	1.2	4.2	4.6	9.2	21.3	3.7	4.4	2.2	7.8	8.6	42.3	4.8	4.3	6.1	1.2	7.1	44.0	2.5	2.5	1.8	10.4	2.5	3.7	0.1	9.8	0.5	0.5	2.3	2.4	2.4	1.0	0.4	0.4	0.0	1.3	0.0	0.0	13.7	3.5	1.5	2.2	0.7	3.0	0.5	1.5	0.7	0.7	13.1	2.2	0.2	1.8	0.6	0.9	3.4	0.6	0.6	0.3	2.1	0.7	1.1	47.9	5.7	0.5	0.4	3.7	0.8	0.7	0.4	1.9	1.3	0.1	1.1	0.8	0.2	0.5	0.5	0.8	1.3	0.3	0.6	3.2	0.4	1.1	5.5	0.5	0.9	1.4	3.8	0.6	1.3	0.4	1.6	0.4	0.1	0.4	0.2	0.2	0.4	0.4	0.4	0.0	0.4	0.4	0.3	0.0	0.2	2.4	0.4	1.3	1.0	0.6	0.4	0.2	0.0	0.0	0.2	0.3	0.1	0.0	8.2	5.6	17.8	9.0	4.9	5.0	4.2	4.6	7.8	3.7
SET	"2PP2A, IPP2A2, PHAPII"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"			880000	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: "	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavourable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	47.2	49.7	66.5	59.3	65.8	71.8	56.5	64.2	61.2	54.4	51.3	55.3	45.6	40.1	64.8	33.1	71.6	51.6	48.9	81.6	63.6	57.3	51.7	57.8	51.2	91.1	65.4	56.1	76.5	61.3	55.0	38.7	65.4	47.3	59.2	56.4	36.3	52.1	46.9	76.3	53.6	45.7	59.0	73.5	62.8	46.8	34.8	58.6	152.9	69.1	46.2	92.7	74.4	84.1	72.2	66.4	43.2	56.5	78.8	77.9	69.7	50.4	57.6	82.9	65.6	24.8	38.9	76.5	41.7	46.2	60.3	41.6	79.2	62.0	130.6	35.3	42.9	94.7	122.5	62.7	69.0	59.5	52.2	75.1	89.7	64.4	55.4	137.0	49.2	32.3	49.1	51.3	103.0	56.3	145.7	53.0	49.3	85.2	114.7	50.6	138.4	61.4	105.0	103.1	105.7	46.5	57.0	84.5	53.1	91.8	61.7	49.8	76.9	42.7	53.9	71.3	53.5	43.9	68.9	41.7	119.8	155.4	33.9	73.0	67.9	34.5	53.9	43.2	58.9	56.5	72.1	72.2	67.9	62.8	52.7	66.3	65.8	77.9	35.4	78.8	45.6	66.4	52.3	69.7	66.5	65.8	64.2	61.2	63.6	57.3	65.4	56.1	47.3	58.6
SETSIP	SETP18	ENSG00000230667	"SET-like protein"	P0DME0	1	92074533-92075441	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.8"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.3"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA063683	Approved		Supported	"Nucleoplasm,Lipid droplets"				Nucleoplasm	"Lipid droplets"	"HPA063683: "	"unprognostic (2.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (7.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.88e-8)"	"unprognostic (3.43e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.35e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	0.0	0.0		0.1		0.3	0.0		0.8	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.1			0.2	0.0	0.2	0.0			0.2	0.0	0.0		0.3		0.0	0.0		0.3	0.0	0.7	0.0	0.0	0.0		0.0	0.0	1.8			0.0		0.0	0.0		0.3	0.2	0.6	0.3	0.1	0.2	0.1	0.6	0.7	0.4	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	1.3	0.5	0.4	0.0	1.2	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.0	0.0	2.3	0.0	1.6	0.5	1.2	1.0	1.4	0.0	0.6	1.5	0.6	1.3	0.9	0.5	0.7	0.2	0.0	0.7	0.4	0.2	0.2	0.7	0.6	1.2	0.0	0.1	1.8	0.0	0.0	0.6	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1										
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397839-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 30.0"	"Group enriched"	"Detected in some"	7	"AN3-CA: 69.1;PC-3: 40.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"memory B-cell: 2.1;naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.4"	"Region enriched"	"Detected in single"	24	"olfactory region: 63.3"	"Low region specificity"	"Detected in some"			HPA054754			Approved	"Lipid droplets,Cytosol"				Cytosol	"Lipid droplets"	"HPA054754: "	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.5	2.1	1.0	2.3	3.5	0.1	1.8	0.7	1.3	0.9	5.0	0.1	2.9	2.9	0.3	6.2	8.6	0.4	4.2	12.9	0.9	1.5	30.0	1.0	4.7	15.4	8.3	0.7	1.4	0.3	0.1	0.5	0.2	3.3	2.6	4.1	0.3	1.2	1.5	3.4	0.4	8.4	10.7	1.0	0.6	3.5	2.0	2.2	0.0	4.6	2.6	1.1	6.8	4.7	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	7.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	3.1	40.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.5	0.7	1.3	0.9	1.5	8.3	0.7	3.3	2.2
VWA8	KIAA0564	ENSG00000102763	"Von Willebrand factor A domain containing 8"	A3KMH1	13	41566837-41961120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039075, HPA045478"	Uncertain		Approved	"Vesicles,Lipid droplets"				"Vesicles, Lipid droplets"		"HPA039075: , HPA045478: "	"unprognostic (9.93e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (8.56e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.44e-1)"	"prognostic favourable (6.38e-14)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.26e-1)"	10.1	15.1	7.1	14.1	9.7	6.3	11.0	11.4	10.5	12.2	10.0	8.2	10.4	8.7	14.9	10.7	9.1	8.3	12.1	16.0	6.7	7.9	21.8	25.8	6.8	8.3	8.8	6.0	9.5	11.1	17.2	16.3	6.4	9.8	8.6	9.6	15.1	15.2	8.7	31.4	7.3	11.1	11.9	6.9	6.9	8.9	5.5	5.6	17.5	9.0	16.4	11.8	11.7	6.9	2.5	2.5	1.8	1.5	4.1	4.9	2.4	4.0	5.9	6.1	8.4	5.8	8.4	5.7	6.5	9.5	5.9	4.7	7.8	6.5	10.8	4.4	5.6	14.5	5.6	15.7	7.4	12.2	10.1	10.1	5.7	9.8	6.2	13.3	1.4	9.8	9.8	5.6	13.5	5.8	9.7	7.7	5.2	5.4	7.5	6.8	9.1	5.7	0.0	3.8	11.2	15.8	14.6	3.8	8.2	8.1	12.7	8.9	5.3	10.2	5.3	4.4	4.7	5.7	6.1	8.0	7.5	16.9	4.9	6.5	5.8	1.8	1.1	0.2	3.4	1.1	4.9	2.3	2.0	2.9	2.5	2.5	2.7	3.5	0.7	4.1	1.5	1.5	1.1	2.4	7.1	9.7	11.4	10.5	6.7	7.9	8.8	6.0	9.8	5.6
ZDHHC11	"FLJ13153, ZNF399"	ENSG00000188818	"Zinc finger DHHC-type containing 11"	Q9H8X9	5	795606-850986	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA057886, HPA069008"	Uncertain		Approved	"Lipid droplets"				"Lipid droplets"		"HPA057886: , HPA069008: "	"unprognostic (2.67e-1)"	"unprognostic (9.76e-3)"	"unprognostic (4.47e-5)"	"unprognostic (5.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (5.23e-5)"	"unprognostic (4.80e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-2)"	1.8	1.4	3.4	1.0	4.2	0.7	2.7	11.0	3.8	1.6	1.5	6.3	1.0	9.5	1.7	2.9	3.2	10.3	1.2	6.4	4.2	3.8	2.0	2.6	7.5	1.0	15.2	1.9	1.5	1.9	1.8	7.8	1.2	10.9	2.7	1.2	1.0	1.4	3.4	2.1	2.7	1.7	1.0	5.0	2.4	5.9	6.3	6.1	1.0	1.1	2.3	1.8	1.0	1.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	7.4	4.1	0.8	1.3	0.3	5.5	0.3	0.1	0.2	0.1	1.0	0.3	3.0	0.8	0.1	6.9	2.2	0.0	0.1	9.0	4.8	0.3	2.6	3.7	0.3	4.3	0.3	0.4	0.3	0.9	1.0	0.0	0.7	1.7	0.2	3.3	0.4	2.6	7.3	2.9	4.5	2.8	4.1	0.2	1.5	4.1	0.7	0.2	0.1	3.1	11.5	0.7	0.4	0.2	6.9	3.9	0.1	5.5	7.7	0.9	0.3	8.9	0.2	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.2	11.0	3.8	4.2	3.8	15.2	1.9	10.9	6.1
ZDHHC11B		ENSG00000206077	"Zinc finger DHHC-type containing 11B"	P0C7U3	5	710360-766952	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 11.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.0;RPMI-8226: 4.4;SCLC-21H: 6.5;THP-1: 7.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"									"HPA057886, HPA069008"	Uncertain		Approved	"Lipid droplets"				"Lipid droplets"		"HPA057886: , HPA069008: "	"unprognostic (2.81e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.79e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (3.98e-4)"	"unprognostic (4.39e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.31e-1)"	0.3	1.8	2.9	0.0	3.7	0.0	0.6	11.7	5.3	0.0	1.1			3.8	0.5	0.4	2.8	3.4	0.5	3.8	3.9	2.9	0.4	0.6	5.3	0.0	2.8		0.8	2.4	1.5	3.7	0.1		0.6	1.9		1.0	0.4	3.3	4.8	5.9	0.0	2.5	3.3	3.8	0.8			0.7		0.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	1.9	0.8	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.2	1.0	0.3	0.0	2.4	5.0	0.2	0.0	3.0	2.3	0.0	1.9	0.9	0.0	1.5	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	4.4	0.1	1.5	6.5	1.9	0.1	0.0	0.6	0.1	7.0	0.1	0.0	2.5	0.0	0.0	2.4	0.8	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1